Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
7.64
-0.03 (-0.39%)
May 22, 2025, 2:45 PM CST
-24.36%
Market Cap 14.91B
Revenue (ttm) 2.07B
Net Income (ttm) -148.24M
Shares Out 1.94B
EPS (ttm) -0.07
PE Ratio n/a
Forward PE 38.35
Dividend 0.25 (3.24%)
Ex-Dividend Date May 23, 2024
Volume 9,271,700
Average Volume 13,378,253
Open 7.67
Previous Close 7.67
Day's Range 7.60 - 7.75
52-Week Range 7.00 - 10.09
Beta 0.12
RSI 58.96
Earnings Date Apr 30, 2025

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. It offers human insulin API and injections; insulin glargine API and injections; insulin aspart API and injections; liraglutide injections; zhennaoning capsules; and diabetes-related medical devices. The company also provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient managem... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.